![Douglas Snyder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Snyder
General Counsel at
IDEAYA BIOSCIENCES, INC.
Net worth: 77 522 $ as of 30/06/2026
Profile
Douglas B. Snyder is currently Chief Legal Officer at IDEAYA Biosciences, Inc. Formerly, Mr. Snyder was Vice-President & Associate General Counsel at GSK Plc from 1999 to 2005, Secretary, Vice President & General Counsel at Eisai, Inc. from 2005 to 2012, Associate General Counsel at US Food & Drug Administration from 1994 to 1999, Secretary, Senior Vice President & General Counsel at Actelion US Holding Co. from 2012 to 2017, and Secretary, Executive VP & Chief Legal Officer at GW Pharmaceuticals Ltd. from 2017 to 2022.
Education includes undergraduate studies at Dickinson College and graduate studies at Columbus School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 2,080 ( 0% ) | 77 522 $ | 30/06/2026 |
Douglas Snyder active positions
| Companies | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | General Counsel | 18/09/2024 |
Former positions of Douglas Snyder
| Companies | Position | End |
|---|---|---|
| GW PHARMACEUTICALS PLC | General Counsel | 01/01/2022 |
Actelion US Holding Co.
 Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | General Counsel | 01/01/2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | General Counsel | 06/05/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2005 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/08/1999 |
Training of Douglas Snyder
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Actelion US Holding Co.
Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Dickinson College
 Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Columbus School of Law
 Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Douglas Snyder
